{
  "id": "everyday#screening_cues_cec49a6e",
  "title_en": "General — Screening Cues",
  "title_vi": "General — Dấu hiệu sàng lọc",
  "text_en": "Other Hallucinogen Intoxication 249 Note: When the drug is smoked, “snorted,” or used intravenously, the onset may be particularly rapid. 1. Vertical or horizontal nystagmus. 2. Hypertension or tachycardia. 3. Numbness or diminished responsiveness to pain. 4. Ataxia. 5. Dysarthria. 6. Muscle rigidity. 7. Seizures or coma. 8. Hyperacusis. D. The signs or symptoms are not attributable to another medical condition and are not better explained by another mental disor- der, including intoxication with another substance. Coding note: The ICD-9-CM code is 292.89. The ICD-10-CM code de- pends on whether there is a comorbid phencyclidine use disorder. If a mild phencyclidine use disorder is comorbid, the ICD-10-CM code is F16.129, and if a moderate or severe phencyclidine use disorder is co- morbid, the ICD-10-CM code is F16.229. If there is no comorbid phen- cyclidine use disorder, then the ICD-10-CM code is F16.929. Other Hallucinogen Intoxication A. Recent use of a hallucinogen (other than phencyclidine). B. Clinically significant problematic behavioral or psychological changes (e.g., marked anxiety or depression, ideas of reference, fear of “losing one’s mind,” paranoid ideation, impaired judg- ment) that developed during, or shortly after, hallucinogen use. C. Perceptual changes occurring in a state of full wakefulness and alertness (e.g., subjective intensification of perceptions, deper- sonalization, derealization, illusions, hallucinations, synesthe- sias) that developed during, or shortly after, hallucinogen use. D. Two (or more) of the following signs developing during, or shortly after, hallucinogen use:",
  "gloss_vi": "Other hallucinogen intoxication 249 note: when the drug is smoked, “snorted,” or used intravenously, the onset may be particularly rapid. 1.",
  "source": "Everyday Essentials",
  "url": "",
  "lang": "en",
  "axes": {
    "type": [
      "clinical",
      "everyday"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "screening_cues",
      "referral"
    ],
    "life_topics": [
      "stress"
    ],
    "advice_section": [],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Screening Cues General — Dấu hiệu sàng lọc Other Hallucinogen Intoxication 249 Note: When the drug is smoked, “snorted,” or used intravenously, the onset may be particularly rapid. 1. Vertical or horizontal nystagmus. 2. Hypertension or tachycardia. 3. Numbness or diminished responsiveness to pain. 4. Ataxia. 5. Dysarthria. 6. Muscle rigidity. 7. Seizures or coma. 8. Hyperacusis. D. The signs or symptoms are not attributable to another medical condition and are not better explained by another mental disor- der, including intoxication with another substance. Coding note: The ICD-9-CM code is 292.89. The ICD-10-CM code de- pends on whether there is a comorbid phencyclidine use disorder. If a mild phencyclidine use disorder is comorbid, the ICD-10-CM code is F16.129, and if a moderate or severe phencyclidine use disorder is co- morbid, the ICD-10-CM code is F16.229. If there is no comorbid phen- cyclidine use disorder, then the ICD-10-CM code is F16.929. Other Hallucinogen Intoxication A. Recent use of a hallucinogen (other than phencyclidine). B. Clinically significant problematic behavioral or psychological changes (e.g., marked anxiety or depression, ideas of reference, fear of “losing one’s mind,” paranoid ideation, impaired judg- ment) that developed during, or shortly after, hallucinogen use. C. Perceptual changes occurring in a state of full wakefulness and alertness (e.g., subjective intensification of perceptions, deper- sonalization, derealization, illusions, hallucinations, synesthe- sias) that developed during, or shortly after, hallucinogen use. D. Two (or more) of the following signs developing during, or shortly after, hallucinogen use: Other hallucinogen intoxication 249 note: when the drug is smoked, “snorted,” or used intravenously, the onset may be particularly rapid. 1."
}